Attached files

file filename
EX-31 - GLOBAL HEALTH VOYAGER INCex31.htm
EX-32 - GLOBAL HEALTH VOYAGER INCex32.htm
EXCEL - IDEA: XBRL DOCUMENT - GLOBAL HEALTH VOYAGER INCFinancial_Report.xls

U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q/A

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended:  June 30, 2011

 

OR

 

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from  ___ to ____

 

Commission File Number 000-31012

 

GLOBAL HEALTH VOYAGER, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   94-3357128
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)
     

7800 Oceanus Drive

Los Angeles, California

 

 

90046

(Address of principal executive offices)   (Zip Code)

 

Registrant's telephone number: (323) 445-4833

 

NT MEDIA CORP. OF CALIFORNIA, INC.

 

(Former Name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant  (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if  any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes o No o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," ”accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer [ ] Accelerated filer [ ]
Non-accelerated filer [ ]  (Do not check if a smaller reporting company) Smaller reporting company [x]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No [x]

 

Number of shares outstanding as of August 15, 2011: 26,842,093 common shares.

 

1
 

GLOBAL HEALTH VOYAGER, INC.

Explanatory Note


 

The purpose of the Amendment No. 1 on Form 10–Q/A to Registrants’s quarterly report on Form 10–Q for the quarter ended June 30, 2011, filed with the Securities and Exchange Commission on August 15, 2011 (the “Form 10–Q”), is solely to furnish Exhibit 101 to the Form 10–Q in accordance with Rule 405 of Regulation S–T.

 

No other changes have been made to the Form 10–Q.  This Amendment No. 1 speaks as of the original filing date of the Form 10–Q, does not reflect events that may have occurred subsequent to the original filing date and does not modify or update in any way disclosures made in the original Form 10–Q.

 

 

2
 

 

ITEM 6.          EXHIBITS

 

Exhibit Number   Description
3.1 (1) Certificate of Incorporation dated March 14, 2000
3.1.1 * Certificate of Incorporation including Certificate of Ownership and Merger dated August 4, 2011
3.2 (1) Bylaws dated March 14, 2000
3.3 (2) Amendment to Certificate of Incorporation dated April 24, 2001
3.4 (3) Certificate of Amendment of Certificate of Incorporation dated July 18, 2007
4.1 (4) 2009 Equity Incentive Plan dated March 6, 2009
4.2 (5) Form of Common Stock Purchase Warrant
10.1 (5) Form of Subscription Agreement
10.1 (5) Form of Convertible Promissory Note
10.2 * Agreement with Deutsche Lufthansa AG
10.3 * Facilitating agreement with AmeriMed Hospitals of Mexico
10.4 * Facilitating agreement with Med-International of Israel
31 **  Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32 **   Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS **  XBRL Instance Document
101.SCH **  XBRL Taxonomy Extension Schema
101.CAL **  XBRL Taxonomy Extension Calculation Linkbase
101.DEF **  XBRL Taxonomy Extension Definition Linkbase
101.LAB **   XBRL Taxonomy Extension Label Linkbase
101.PRE **  XBRL Taxonomy Presentation Linkbase

 

* Previously filed or furnished as an exhibit to Registrant’s quarterly report of Form 10–Q for the quarter ended June 30, 2011.

**Filed herewith.

(1) Filed as an exhibit to the Company’s Registration Statement (File No. 333-38322), Amendment No. 1, on Form SB-2/A on August 23, 2000.

(2) Filed as an exhibit to the Company’s Current Report on Form 8-K filed on May 1, 2001.

(3) Filed as an exhibit to the Company’s Current Report on Form 8-K filed on July 19, 2007.

(4) Filed as an exhibit to the Company’s Registration Statement (File No. 333-157748) on Form S-8 filed on March 6, 2009.

(5) Filed as an exhibit to the Company's Current Report on Form 8-K filed on August 3, 2011.

 

3
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  GLOBAL HEALTH VOYAGER, INC.  
       
Dated:   August 17, 2011   /s/  Ali Moussavi  
    Ali Moussavi,  
    President, Chief Executive Officer (Principal Executive Officer), and Acting Chief Financial Officer (Acting Principal Financial Officer)  

 

4
 

EXHIBIT INDEX

 

 

Exhibit Number   Description
3.1 (1) Certificate of Incorporation dated March 14, 2000
3.1.1 * Certificate of Incorporation including Certificate of Ownership and Merger dated August 4, 2011
3.2 (1) Bylaws dated March 14, 2000
3.3 (2) Amendment to Certificate of Incorporation dated April 24, 2001
3.4 (3) Certificate of Amendment of Certificate of Incorporation dated July 18, 2007
4.1 (4) 2009 Equity Incentive Plan dated March 6, 2009
4.2 (5) Form of Common Stock Purchase Warrant
10.1 (5) Form of Subscription Agreement
10.1 (5) Form of Convertible Promissory Note
10.2 * Agreement with Deutsche Lufthansa AG
10.3 * Facilitating agreement with AmeriMed Hospitals of Mexico
10.4 * Facilitating agreement with Med-International of Israel
31 **   Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32 **   Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS **  XBRL Instance Document
101.SCH **  XBRL Taxonomy Extension Schema
101.CAL **  XBRL Taxonomy Extension Calculation Linkbase
101.DEF **  XBRL Taxonomy Extension Definition Linkbase
101.LAB **   XBRL Taxonomy Extension Label Linkbase
101.PRE **  XBRL Taxonomy Presentation Linkbase

 

 

* Previously filed or furnished as an exhibit to Registrant’s quarterly report of Form 10–Q for the quarter ended June 30, 2011.

**Filed herewith.

 

(1) Filed as an exhibit to the Company’s Registration Statement (File No. 333-38322), Amendment No. 1, on Form SB-2/A on August 23, 2000.

(2) Filed as an exhibit to the Company’s Current Report on Form 8-K filed on May 1, 2001.

(3) Filed as an exhibit to the Company’s Current Report on Form 8-K filed on July 19, 2007.

(4) Filed as an exhibit to the Company’s Registration Statement (File No. 333-157748) on Form S-8 filed on March 6, 2009.

(5) Filed as an exhibit to the Company's Current Report on Form 8-K filed on August 3, 2011.

5